Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed, with the Dow Jones index gaining around 100 points on Thursday.

Shares of Knight-Swift Transportation Holdings Inc. KNX rose sharply during Thursday's session as the company reported better-than-expected fourth-quarter adjusted earnings results.

Knight-Swift reported quarterly earnings of 36 cents per share which beat the analyst consensus estimate of 33 cents per share. The company reported quarterly sales of $1.86 billion which missed the analyst consensus estimate of $1.88 billion.

Knight-Swift Transportation shares gained 5% to $57.77 on Thursday.

Here are some other big stocks recording gains in today's session.

Precigen, Inc. PGEN shares surged 20.3% to $1.3600. HC Wainwright & Co. analyst Swayampakula Ramakanth reiterated Precigen with a Buy and raised the price target from $4 to $6.
Evolv Technologies Holdings, Inc. EVLV rose 15.4% to $3.7149 as the company provided a positive update on strategic metrics for the three-month period ending December 31, 2024.
MicroVision, Inc. MVIS climbed 15.4% to $1.8350.
TAL Education Group TAL gained 15.3% to $10.53 after the company reported better-than-expected third-quarter financial results.
LSI Industries Inc. LYTS shares jumped 15% to $22.73 after the company reported better-than-expected second-quarter financial results.
OSI Systems, Inc. OSIS gained 13.8% to $192.43 following upbeat quarterly results.
Himax Technologies, Inc. HIMX shares rose 11.3% to $11.04.
MarineMax, Inc. HZO jumped 9.7% to $30.67 after the company reported better-than-expected quarterly adjusted EPS results.
Blaize Holdings, Inc. BZAI shares gained 9.5% to $6.92.
GE Aerospace GE gained 9.1% to $205.55 following better-than-expected quarterly earnings.
WNS (Holdings) Limited WNS rose 8.4% to $53.68 following strong quarterly sales.
Guidewire Software, Inc. GWRE gained 7.5% to $197.19. Guidewire Software will replace Arrowhead Pharmaceuticals in the S&P MidCap 400, effective prior to opening of trading on Jan. 27.